Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Apr 28, 2016
This presentation was delivered at the Electronic Imaging Symposium 2016 (14-18 February 2016) held in San Francisco, CA USA.
Title: Illuminating a Bright Future for Medicine - Novel Tools for Optical Imaging and Sensing at the Microscale and Nanoscale.
Speaker: Audrey (Ellerbee) Bowden, Stanford University, USA
Synopsis: Cancer. Infertility. Hearing loss. Each of these phrases can bring a ray of darkness into an otherwise happy life. The Stanford Biomedical Optics group, led by Professor Audrey Bowden, aims to develop and deploy novel optical technologies to solve interdisciplinary challenges in the clinical and basic sciences. In short, we use light to image life—and in so doing, illuminate new paths to better disease diagnosis, management and treatment. In this talk, I will discuss our recent efforts to design, fabricate and/or construct new hardware, software and systems-level biomedical optics tools to attack problems in skin cancer, bladder cancer, hearing loss and infertility. Our efforts span development of new fabrication techniques for 3D tissue-mimicking phantoms, new strategies for creating large mosaics and 3D models of biomedical data, machine-learning classifiers for automated detection of disease, novel system advances for multiplexed optical coherence tomography and low-cost technologies for point-of-care diagnostics.
Biography: Audrey K (Ellerbee) Bowden, PhD is an Assistant Professor of Electrical Engineering at Stanford University. Dr. Bowden directs the Stanford Biomedical Optics group, whose mission is to develop and deploy novel tools for optical imaging at the microscale and nanoscale. Their applications of interest span clinical and basic science domains. The group also has a particular interest in the development of low- cost, portable technologies suited for use in poorly resourced environments. Building on their expertise and experience with interferometry, they aim to create innovative technologies that serve as integral complements to the toolkits of biologists and clinicians, as well as use their own technologies to study various cellular phenomena relevant to disease.